APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liranaftate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liranaftate Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchLiranaftate Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liranaftate Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Liranaftate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liranaftate Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Liranaftate Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Liranaftate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liranaftate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liranaftate market include Zenyaku Kogyo Company, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd and Zhejiang Wansheng Pharmaceutical Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Liranaftate market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liranaftate and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liranaftate revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Liranaftate market.

Liranaftate Segment by Company

Zenyaku Kogyo Company

Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd

Nanjing Changao Pharmaceutical Co. Ltd

Tianfang Pharmaceutical Co., Ltd

Yangzijiang Pharmaceutical Group Co. Ltd

Zhejiang Wansheng Pharmaceutical Co. Ltd

Liranaftate Segment by Type

Cream

Spray

Liranaftate Segment by Application

Tinea Pedis

Jock Itch

Liranaftate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Liranaftate status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Liranaftate key companies, revenue, market share, and recent developments.

3. To split the Liranaftate breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Liranaftate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liranaftate significant trends, drivers, influence factors in global and regions.

6. To analyze Liranaftate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liranaftate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liranaftate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liranaftate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liranaftate industry.

Chapter 3: Detailed analysis of Liranaftate company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Liranaftate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Liranaftate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liranaftate Industry Trends Table 2. Liranaftate Industry Drivers Table 3. Liranaftate Industry Opportunities and Challenges Table 4. Liranaftate Industry Restraints Table 5. Global Liranaftate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liranaftate Revenue Share by Company (2021-2026) Table 7. Global Liranaftate Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Liranaftate Key Company Manufacturing Base & Headquarters Table 9. Global Liranaftate Company, Product Type & Application Table 10. Global Liranaftate Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Liranaftate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cream Table 15. Significant Companies of Spray Table 16. Global Liranaftate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Liranaftate Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Liranaftate Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Liranaftate Sales Value Share by Type (2021-2026) Table 20. Global Liranaftate Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Tinea Pedis Table 22. Significant Companies of Jock Itch Table 23. Global Liranaftate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Liranaftate Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Liranaftate Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Liranaftate Sales Value Share by Application (2021-2026) Table 27. Global Liranaftate Sales Value Share by Application (2027-2032) Table 28. Global Liranaftate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Liranaftate Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Liranaftate Sales Value Share by Region (2021-2026) Table 31. Global Liranaftate Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Liranaftate Sales Value Share by Region (2027-2032) Table 33. Global Liranaftate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Liranaftate Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Liranaftate Sales Value Market Share by Country (2021-2026) Table 36. Global Liranaftate Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Liranaftate Sales Value Market Share by Country (2027-2032) Table 38. Zenyaku Kogyo Company Company Information Table 39. Zenyaku Kogyo Company Business Overview Table 40. Zenyaku Kogyo Company Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Zenyaku Kogyo Company Liranaftate Product Portfolio Table 42. Zenyaku Kogyo Company Recent Development Table 43. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information Table 44. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview Table 45. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 47. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Development Table 48. Nanjing Changao Pharmaceutical Co. Ltd Company Information Table 49. Nanjing Changao Pharmaceutical Co. Ltd Business Overview Table 50. Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 52. Nanjing Changao Pharmaceutical Co. Ltd Recent Development Table 53. Tianfang Pharmaceutical Co., Ltd Company Information Table 54. Tianfang Pharmaceutical Co., Ltd Business Overview Table 55. Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio Table 57. Tianfang Pharmaceutical Co., Ltd Recent Development Table 58. Yangzijiang Pharmaceutical Group Co. Ltd Company Information Table 59. Yangzijiang Pharmaceutical Group Co. Ltd Business Overview Table 60. Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio Table 62. Yangzijiang Pharmaceutical Group Co. Ltd Recent Development Table 63. Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information Table 64. Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview Table 65. Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 67. Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Development Table 68. Research Programs/Design for This Report Table 69. Authors List of This Report Table 70. Secondary Sources Table 71. Primary Sources List of Figures Figure 1. Liranaftate Product Image Figure 2. Global Liranaftate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liranaftate Market Size (2021-2032) & (US$ Million) Figure 4. Global Liranaftate Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cream Image Figure 8. Spray Image Figure 9. Global Liranaftate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Liranaftate Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Liranaftate Sales Value Share by Type (2021-2032) Figure 12. Tinea Pedis Image Figure 13. Jock Itch Image Figure 14. Global Liranaftate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Liranaftate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Liranaftate Sales Value Share by Application (2021-2032) Figure 17. Global Liranaftate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Liranaftate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Liranaftate Sales Value (2021-2032) & (US$ Million) Figure 20. North America Liranaftate Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Liranaftate Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Liranaftate Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Liranaftate Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Liranaftate Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Liranaftate Sales Value (2021-2032) & (US$ Million) Figure 26. South America Liranaftate Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Liranaftate Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Liranaftate Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Liranaftate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Liranaftate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Liranaftate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cream
  • Spray
Applications
  • Tinea Pedis
  • Jock Itch
Companies covered
  • Zenyaku Kogyo Company
  • Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
  • Nanjing Changao Pharmaceutical Co. Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Yangzijiang Pharmaceutical Group Co. Ltd
  • Zhejiang Wansheng Pharmaceutical Co. Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liranaftate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liranaftate Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Liranaftate Market Dynamics
  1. 2.1 Liranaftate Industry Trends
  2. 2.2 Liranaftate Industry Drivers
  3. 2.3 Liranaftate Industry Opportunities and Challenges
  4. 2.4 Liranaftate Industry Restraints
3 Liranaftate Market by Company
  1. 3.1 Global Liranaftate Company Revenue Ranking in 2025
  2. 3.2 Global Liranaftate Revenue by Company (2021-2026)
  3. 3.3 Global Liranaftate Company Ranking (2024-2026)
  4. 3.4 Global Liranaftate Company Manufacturing Base and Headquarters
  5. 3.5 Global Liranaftate Company Product Type and Application
  6. 3.6 Global Liranaftate Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Liranaftate Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Liranaftate Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Liranaftate Market by Type
  1. 4.1 Liranaftate Type Introduction
  2. 4.1.1 Cream
  3. 4.1.2 Spray
  4. 4.2 Global Liranaftate Sales Value by Type
  5. 4.2.1 Global Liranaftate Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liranaftate Sales Value by Type (2021-2032)
  7. 4.2.3 Global Liranaftate Sales Value Share by Type (2021-2032)
5 Liranaftate Market by Application
  1. 5.1 Liranaftate Application Introduction
  2. 5.1.1 Tinea Pedis
  3. 5.1.2 Jock Itch
  4. 5.2 Global Liranaftate Sales Value by Application
  5. 5.2.1 Global Liranaftate Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Liranaftate Sales Value by Application (2021-2032)
  7. 5.2.3 Global Liranaftate Sales Value Share by Application (2021-2032)
6 Liranaftate Regional Value Analysis
  1. 6.1 Global Liranaftate Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liranaftate Sales Value by Region (2021-2032)
  3. 6.2.1 Global Liranaftate Sales Value by Region: 2021-2026
  4. 6.2.2 Global Liranaftate Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liranaftate Sales Value (2021-2032)
  7. 6.3.2 North America Liranaftate Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Liranaftate Sales Value (2021-2032)
  10. 6.4.2 Europe Liranaftate Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Liranaftate Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Liranaftate Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Liranaftate Sales Value (2021-2032)
  16. 6.6.2 South America Liranaftate Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Liranaftate Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Liranaftate Sales Value Share by Country, 2025 VS 2032
7 Liranaftate Country-level Value Analysis
  1. 7.1 Global Liranaftate Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liranaftate Sales Value by Country (2021-2032)
  3. 7.2.1 Global Liranaftate Sales Value by Country (2021-2026)
  4. 7.2.2 Global Liranaftate Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Liranaftate Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Liranaftate Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Liranaftate Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Liranaftate Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Liranaftate Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Liranaftate Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Liranaftate Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Liranaftate Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Liranaftate Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Liranaftate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Liranaftate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Liranaftate Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Liranaftate Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Liranaftate Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Liranaftate Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Liranaftate Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Liranaftate Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Liranaftate Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Liranaftate Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Liranaftate Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Liranaftate Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Liranaftate Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Liranaftate Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Liranaftate Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Liranaftate Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Liranaftate Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Liranaftate Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Liranaftate Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Liranaftate Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Liranaftate Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Liranaftate Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Liranaftate Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Liranaftate Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Liranaftate Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Liranaftate Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Liranaftate Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Liranaftate Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Liranaftate Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Liranaftate Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Liranaftate Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Liranaftate Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Liranaftate Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Liranaftate Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Liranaftate Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Liranaftate Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Liranaftate Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Liranaftate Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Liranaftate Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Liranaftate Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Liranaftate Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Liranaftate Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Liranaftate Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Liranaftate Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Liranaftate Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Liranaftate Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Liranaftate Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Liranaftate Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Liranaftate Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Liranaftate Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Liranaftate Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Liranaftate Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Liranaftate Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Liranaftate Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Liranaftate Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Liranaftate Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Liranaftate Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Liranaftate Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Liranaftate Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Liranaftate Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Liranaftate Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Liranaftate Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Liranaftate Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Liranaftate Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Liranaftate Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Liranaftate Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Liranaftate Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Liranaftate Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Liranaftate Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Liranaftate Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Liranaftate Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Liranaftate Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Liranaftate Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Liranaftate Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Liranaftate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zenyaku Kogyo Company
  2. 8.1.1 Zenyaku Kogyo Company Company Information
  3. 8.1.2 Zenyaku Kogyo Company Business Overview
  4. 8.1.3 Zenyaku Kogyo Company Liranaftate Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zenyaku Kogyo Company Liranaftate Product Portfolio
  6. 8.1.5 Zenyaku Kogyo Company Recent Developments
  7. 8.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
  8. 8.2.1 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information
  9. 8.2.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview
  10. 8.2.3 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  12. 8.2.5 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Developments
  13. 8.3 Nanjing Changao Pharmaceutical Co. Ltd
  14. 8.3.1 Nanjing Changao Pharmaceutical Co. Ltd Company Information
  15. 8.3.2 Nanjing Changao Pharmaceutical Co. Ltd Business Overview
  16. 8.3.3 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  18. 8.3.5 Nanjing Changao Pharmaceutical Co. Ltd Recent Developments
  19. 8.4 Tianfang Pharmaceutical Co., Ltd
  20. 8.4.1 Tianfang Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio
  24. 8.4.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Yangzijiang Pharmaceutical Group Co. Ltd
  26. 8.5.1 Yangzijiang Pharmaceutical Group Co. Ltd Company Information
  27. 8.5.2 Yangzijiang Pharmaceutical Group Co. Ltd Business Overview
  28. 8.5.3 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio
  30. 8.5.5 Yangzijiang Pharmaceutical Group Co. Ltd Recent Developments
  31. 8.6 Zhejiang Wansheng Pharmaceutical Co. Ltd
  32. 8.6.1 Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information
  33. 8.6.2 Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview
  34. 8.6.3 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  36. 8.6.5 Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst